BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

LifeScience

GSK Secures License for Elsie Biotechnologies' Cutting-Edge Discovery Platform

Kevin Green, Chief Operating Officer of Elsie Biotechnologies, expressed enthusiasm, stating, "We are pleased that GSK ha...

February 15, 2024 | News

Brii Biosciences Secures Intellectual Property Rights for HBV Treatment from VBI Vaccines

Brii Biosciences Limited ("Brii Bio"), a leader in developing innovative treatments for diseases with significant unmet needs, has announced a strategic ac...

February 14, 2024 | News

William Lin Discusses QIAGEN's Role in Transforming Healthcare in Asia-Pacific with Innovative Molecular Diagnostics

In a significant stride towards enhancing healthcare diagnostics in the Asia-Pacific region, QIAGEN has recently garnered attention with the approval of it...

February 13, 2024 | Interaction

Gilead Sciences Bolsters Liver Portfolio Through Acquisition of CymaBay Therapeutics

Gilead Sciences, Inc. and CymaBay Therapeutics, Inc. announced today a definitive agreement whereby Gilead will acquire CymaBay for $32.50 ...

February 13, 2024 | News

Cytiva and LevitasBio unite to revolutionize single-cell workflow, fast-tracking therapeutic development

Technologies work together to simplify single-cell workflows, saving time for academic researchers. Combined VIA Extractor and LeviCell system a...

February 12, 2024 | News

Twist Bioscience and Element Biosciences Collaborate on Exome Sequencing for AVITI System

Twist Bioscience Corporation a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, an...

February 07, 2024 | News

SCIEX Enhances High-Throughput Screening with Echo® MS+ System Expansion

The Echo® MS+ system unlocks enhanced high-throughput screening capability by bringing acoustic ejection mass spectrometry (AEMS) approaches to th...

February 02, 2024 | News

Revvity CEO Prahlad Singh Highlights Resilience and Innovation Amidst Industry Challenges in 2023

Revvity, Inc. (NYSE: RVTY) announced robust financial results for Q4 2023 and the full year ending December 31, 2023. Fourth Quarter 2023 Highlights: ...

February 02, 2024 | Company results

Merck Launches Digital Hub in Singapore to Drive Healthcare and Semiconductor Innovations Globally

Hub to drive innovation and research in healthcare and semi-conductor industries with Syntropy™ and Athinia™ platforms Forms a glo...

January 31, 2024 | News

Merck's Strategic Agreement with Heavy Water Board Boosts Local Manufacturing for Deuterated Compounds in India

In a recent interview with BioPharma APAC, Jean Charles Wirth, Executive Vice President of Science & Laboratory Solutions at Merck, sheds light...

January 26, 2024 | Interview

Merck and Mycenax Biotech Forge Partnership for Bioprocessing Innovation

Merck announces a non-binding MoU with Mycenax Biotech to optimize bioprocessing production of life-changing biological therapies Integrates company&rsq...

January 24, 2024 | News

Merck's JAVELIN Bladder Regimen Shines in Real-World Data, Elevating Standard Care for Urothelial Carcinoma

Merck, a distinguished science and technology company, has announced groundbreaking real-world data that further solidify the JAVELIN Bladder regimen as a ...

January 23, 2024 | News

Thermo Fisher's RNA Facility in Monza, Italy, Gains GMP Approval from Italian Medicines Agency (AIFA)

Thermo Fisher Scientific, the world leader in serving science, has received Good Manufacturing Practice (GMP) approval from the Italian Medicines Agency (A...

January 19, 2024 | News

Geneoscopy Challenges Exact Sciences’ Patent with Inter Partes Review Petition

Geneoscopy, Inc., a life sciences company focused on developing diagnostic tests for the advancement of gastrointestinal health, today announced that it ha...

January 15, 2024 | News

Stay Connected